TUL the sterile active pharmaceutical ingredient of Ampicillin Sodium obtained the European Pharmacopoeia Compliance Certificate (CEP Certificate) issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM)

Date：2025-10-20

On September 10, the sterile active pharmaceutical ingredient of Ampicillin Sodium produced by Zhuhai United Laboratories Co., Ltd. obtained the European Pharmacopoeia Compliance Certificate (CEP Certificate) issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), with the certificate number CEP 2024-414.

Previous： TUL was awarded the 'Best ESG Pioneer Practice Listed Company Award'

Next： TUL held its 2025 Mid-Year Results Press Conference in Hong Kong